BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27984807)

  • 1. BRAF V600E mutation in epilepsy-associated glioneuronal tumors: Prevalence and correlation with clinical features in a Chinese population.
    Zhang YX; Shen CH; Guo Y; Zheng Y; Zhu JM; Ding Y; Tang YL; Wang S; Ding MP
    Seizure; 2017 Feb; 45():102-106. PubMed ID: 27984807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy-related protein expression was associated with BRAF V600E mutation in epilepsy associated glioneuronal tumors.
    Shen CH; Zhang YX; Xu JH; Zhu QB; Zhu JM; Guo Y; Ding Y; Wang S; Ding MP
    Epilepsy Res; 2017 Sep; 135():123-130. PubMed ID: 28667867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors.
    Prabowo AS; Iyer AM; Veersema TJ; Anink JJ; Schouten-van Meeteren AY; Spliet WG; van Rijen PC; Ferrier CH; Capper D; Thom M; Aronica E
    Brain Pathol; 2014 Jan; 24(1):52-66. PubMed ID: 23941441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
    Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
    Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
    [No Abstract]   [Full Text] [Related]  

  • 5. Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression.
    Chappé C; Padovani L; Scavarda D; Forest F; Nanni-Metellus I; Loundou A; Mercurio S; Fina F; Lena G; Colin C; Figarella-Branger D
    Brain Pathol; 2013 Sep; 23(5):574-83. PubMed ID: 23442159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
    Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
    J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs).
    Kakkar A; Majumdar A; Kumar A; Tripathi M; Pathak P; Sharma MC; Suri V; Tandon V; Chandra SP; Sarkar C
    Epilepsy Res; 2016 Nov; 127():141-151. PubMed ID: 27599148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics of BRAF V600E Gene Mutation in Patients of Epilepsy-Associated Brain Tumor: a Meta-analysis.
    Xing H; Song Y; Zhang Z; Koch PD
    J Mol Neurosci; 2021 Sep; 71(9):1815-1824. PubMed ID: 33791912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas.
    Martinoni M; Marucci G; de Biase D; Rubboli G; Volpi L; Riguzzi P; Marliani F; Toni F; Naldi I; Bisulli F; Tinuper P; Michelucci R; Baruzzi A; Tallini G; Giulioni M
    J Clin Neurosci; 2015 Aug; 22(8):1250-3. PubMed ID: 25937573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.
    Ho CY; Mobley BC; Gordish-Dressman H; VandenBussche CJ; Mason GE; Bornhorst M; Esbenshade AJ; Tehrani M; Orr BA; LaFrance DR; Devaney JM; Meltzer BW; Hofherr SE; Burger PC; Packer RJ; Rodriguez FJ
    Acta Neuropathol; 2015 Oct; 130(4):575-85. PubMed ID: 26264609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
    Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical and pathological features of low-grade epilepsy-associated glioneuronal tumors.
    Xie M; Wang X; Qiao J; Zhou J; Guan Y; Li T; Qi X; Luan G
    Sci Rep; 2022 Oct; 12(1):18163. PubMed ID: 36307486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship among clinical, pathological and bio-molecular features in low-grade epilepsy-associated neuroepithelial tumors.
    Vornetti G; Marucci G; Zenesini C; de Biase D; Michelucci R; Tinuper P; Tallini G; Giulioni M
    J Clin Neurosci; 2017 Oct; 44():158-163. PubMed ID: 28673671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizure and cognitive outcomes after resection of glioneuronal tumors in children.
    Faramand AM; Barnes N; Harrison S; Gunny R; Jacques T; Tahir MZ; Varadkar SM; Cross HJ; Harkness W; Tisdall MM
    Epilepsia; 2018 Jan; 59(1):170-178. PubMed ID: 29178251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases.
    Capper D; Berghoff AS; Magerle M; Ilhan A; Wöhrer A; Hackl M; Pichler J; Pusch S; Meyer J; Habel A; Petzelbauer P; Birner P; von Deimling A; Preusser M
    Acta Neuropathol; 2012 Feb; 123(2):223-33. PubMed ID: 22012135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
    Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells.
    Koelsche C; Wöhrer A; Jeibmann A; Schittenhelm J; Schindler G; Preusser M; Lasitschka F; von Deimling A; Capper D
    Acta Neuropathol; 2013 Jun; 125(6):891-900. PubMed ID: 23435618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology.
    Hatae R; Hata N; Suzuki SO; Yoshimoto K; Kuga D; Murata H; Akagi Y; Sangatsuda Y; Iwaki T; Mizoguchi M; Iihara K
    Neuropathology; 2017 Jun; 37(3):191-199. PubMed ID: 27792249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic landscape of ganglioglioma.
    Pekmezci M; Villanueva-Meyer JE; Goode B; Van Ziffle J; Onodera C; Grenert JP; Bastian BC; Chamyan G; Maher OM; Khatib Z; Kleinschmidt-DeMasters BK; Samuel D; Mueller S; Banerjee A; Clarke JL; Cooney T; Torkildson J; Gupta N; Theodosopoulos P; Chang EF; Berger M; Bollen AW; Perry A; Tihan T; Solomon DA
    Acta Neuropathol Commun; 2018 Jun; 6(1):47. PubMed ID: 29880043
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Kakkar A; Majumdar A; Pathak P; Kumar A; Kumari K; Tripathi M; Sharma MC; Suri V; Tandon V; Chandra SP; Sarkar C
    Neurol India; 2017; 65(5):1076-1082. PubMed ID: 28879901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.